Published in Ann Surg on October 01, 2003
Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J (2006) 1.62
Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg (2012) 1.18
Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med (2008) 1.15
Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant (2009) 1.13
Left ventricular assist device-related infections: past, present and future. Expert Rev Med Devices (2011) 1.10
A review of ethical considerations for ventricular assist device placement in older adults. Aging Dis (2013) 0.88
Past and Present of Total Artificial Heart Therapy: A Success Story. Med Sci Monit Basic Res (2015) 0.87
Assessing technological change in cardiothoracic surgery. Semin Thorac Cardiovasc Surg (2009) 0.86
Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support. J Artif Organs (2015) 0.85
Left Ventricular Assist Devices as Destination Therapy for End-stage Heart Failure. Curr Treat Options Cardiovasc Med (2004) 0.80
Left Ventricular Assist Devices for the Treatment of Congestive Heart Failure. Curr Treat Options Cardiovasc Med (2005) 0.78
The cost-utility of left ventricular assist devices for end-stage heart failure patients ineligible for cardiac transplantation: a systematic review and critical appraisal of economic evaluations. Ann Cardiothorac Surg (2014) 0.77
Mechanical circulatory support devices as destination therapy-current evidence. Ann Cardiothorac Surg (2014) 0.76
Management of advanced heart failure in the elderly: ethics, economics, and resource allocation in the technological era. Cardiol Res Pract (2012) 0.75
The management of mechanical hearts. Trans Am Clin Climatol Assoc (2005) 0.75
Left ventricular assist devices: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant (1994) 2.36
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16
Mechanical cardiac-support devices--dreams and devilish details. N Engl J Med (2001) 1.21
Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation (1995) 1.16
Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation (2001) 1.08
Capturing the unexpected benefits of medical research. N Engl J Med (1998) 0.98
Treatment of symptomatic venous thromboembolism: improving outcomes. Semin Thromb Hemost (2002) 0.95
Selective anticoagulation with active site blocked factor IXa in synthetic patch vascular repair results in decreased blood loss and operative time. ASAIO J (1998) 0.86
Evolving costs of long-term left ventricular assist device implantation. Ann Thorac Surg (1997) 0.85
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92
Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg (2010) 3.45
Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA (2005) 3.37
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Quantitative gait markers and incident fall risk in older adults. J Gerontol A Biol Sci Med Sci (2009) 3.01
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant (2006) 2.86
Why consider vaginal drug administration? Fertil Steril (2004) 2.54
INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant (2009) 2.49
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol (2008) 2.40
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. Ann Surg (2005) 2.25
Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Ann Thorac Surg (2006) 2.17
Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci (2012) 2.12
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc (2008) 2.00
Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg (2007) 1.99
Endometrial ablation: is tubal ligation a risk factor for hysterectomy. J Minim Invasive Gynecol (2013) 1.99
Within-person across-neuropsychological test variability and incident dementia. JAMA (2008) 1.98
Managing the prevention of retained surgical instruments: what is the value of counting? Ann Surg (2008) 1.92
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome. Nucleic Acids Res (2005) 1.89
Zinc Finger Database (ZiFDB): a repository for information on C2H2 zinc fingers and engineered zinc-finger arrays. Nucleic Acids Res (2008) 1.87
Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant (2006) 1.84
Picture-based memory impairment screen for dementia. J Am Geriatr Soc (2012) 1.82
Effect of gender on long-term survival after abdominal aortic aneurysm repair based on results from the Medicare national database. J Vasc Surg (2011) 1.81
Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower risk-adjusted mortality rates? Circulation (2003) 1.80
Motor stereotypies in children with autism and other developmental disorders. Dev Med Child Neurol (2009) 1.78
Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology (2013) 1.75
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Effect of cognitive remediation on gait in sedentary seniors. J Gerontol A Biol Sci Med Sci (2010) 1.67
Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest (2008) 1.64
Antibiotic resistance: global response needed. Lancet Infect Dis (2013) 1.64
Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant (2004) 1.56
Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet (2013) 1.56
National trend in prevalence, cost, and discharge disposition after subdural hematoma from 1998-2007. Crit Care Med (2011) 1.53
Factors influencing long-term pessary use. Int Urogynecol J (2010) 1.51
Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg (2008) 1.51
The effect of vaginal speculum lubrication on the rate of unsatisfactory cervical cytology diagnosis. Obstet Gynecol (2002) 1.49
Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. Ann Thorac Surg (2004) 1.46
Kyphoplasty and vertebroplasty: trends in use in ambulatory and inpatient settings. Spine J (2011) 1.41
Performance variance on walking while talking tasks: theory, findings, and clinical implications. Age (Dordr) (2013) 1.40
Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA (2010) 1.35
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med (2005) 1.35
Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes (2010) 1.32
Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis (2004) 1.32
Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg (2004) 1.31
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant (2010) 1.28
Patient selection for left ventricular assist devices. Eur J Heart Fail (2010) 1.25
Self-reported difficulty in climbing up or down stairs in nondisabled elderly. Arch Phys Med Rehabil (2008) 1.24
Correlation of the Tei index with invasive measurements of ventricular function in a porcine model. J Am Soc Echocardiogr (2003) 1.23
Resident physician attire: does it make a difference to our patients? Am J Obstet Gynecol (2004) 1.22
High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest (2009) 1.22
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. J Am Coll Cardiol (2004) 1.18
Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci (2011) 1.18
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Mobility stress test approach to predicting frailty, disability, and mortality in high-functioning older adults. J Am Geriatr Soc (2012) 1.16
The relationship between attention and gait in aging: facts and fallacies. Motor Control (2012) 1.15
Neurological gait abnormalities and risk of falls in older adults. J Neurol (2009) 1.15
Does a surgical simulator improve resident operative performance of laparoscopic tubal ligation? Am J Obstet Gynecol (2007) 1.15
Agreement between women's and providers' assessment of hormonal contraceptive risk factors. Contraception (2006) 1.14
Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J Thorac Cardiovasc Surg (2009) 1.14
Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg (2004) 1.12
Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties. J Am Geriatr Soc (2012) 1.12
Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg (2007) 1.12
Analysis of a physician tool for evaluating dysphagia on an inpatient stroke unit: the modified Mann Assessment of Swallowing Ability. J Stroke Cerebrovasc Dis (2010) 1.11
Hull down on the horizon: A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) trial. Stroke (2012) 1.11
Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J Am Pharm Assoc (2003) (2008) 1.10
Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation (2003) 1.09
Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg (2011) 1.09
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 1.08
A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol (2004) 1.08
Lovastatin-induced apoptosis in human melanoma cell lines. Melanoma Res (2005) 1.06
Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging (2008) 1.05
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J Thorac Cardiovasc Surg (2008) 1.04
A statewide experience with endovascular abdominal aortic aneurysm repair: rapid diffusion with excellent early results. J Vasc Surg (2004) 1.04
Prospective, multicenter study of ventricular assist device infections. Circulation (2013) 1.03